Cargando…
Therapeutic Potential of Targeting Complement C5a Receptors in Diabetic Kidney Disease
Diabetic kidney disease (DKD) affects 30–40% of patients with diabetes and is currently the leading cause of end-stage renal disease (ESRD). The activation of the complement cascade, a highly conserved element of the innate immune system, has been implicated in the pathogenesis of diabetes and its c...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218149/ https://www.ncbi.nlm.nih.gov/pubmed/37240105 http://dx.doi.org/10.3390/ijms24108758 |